Suppr超能文献

鉴别肝转移瘤与原发性肝癌:一项对经组织病理学确诊患者的影像学和病理特征的回顾性研究

Differentiating Liver Metastases from Primary Liver Cancer: A Retrospective Study of Imaging and Pathological Features in Patients with Histopathological Confirmation.

作者信息

Ghenciu Laura Andreea, Grigoras Mirela Loredana, Rosu Luminioara Maria, Bolintineanu Sorin Lucian, Sima Laurentiu, Cretu Octavian

机构信息

Department of Functional Sciences, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Department of Anatomy and Embryology, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.

出版信息

Biomedicines. 2025 Jan 11;13(1):164. doi: 10.3390/biomedicines13010164.

Abstract

This study aimed to identify and analyze imaging and pathological features that differentiate liver metastases from primary liver cancer in patients with histopathological confirmation, and to evaluate the diagnostic accuracy of imaging modalities. This retrospective study included 137 patients who underwent liver biopsy or resection between 2016 and 2024, comprising 126 patients with liver metastases and 11 patients with primary liver cancer (hepatocellular carcinoma). Imaging features on contrast-enhanced MRI were evaluated, including lesion number, size, margins, enhancement patterns, presence of capsule, T1/T2 signal characteristics, diffusion-weighted imaging (DWI) signal, and portal vein thrombosis. Laboratory data such as liver function tests and alpha-fetoprotein (AFP) levels were collected. Pathological features recorded included tumor differentiation, vascular invasion, necrosis, and fibrosis. Statistical analyses were performed using chi-squared tests, -tests, and logistic regression, with a significance level of < 0.05. The diagnostic accuracy of imaging features was assessed using receiver operating characteristic (ROC) curve analysis. Liver metastases were more likely to present as multiple lesions (82.5% vs. 27.3%, < 0.001), had irregular margins (78.6% vs. 36.4%, = 0.002), rim enhancement (74.6% vs. 18.2%, < 0.001), and were hypointense on T1-weighted images (85.7% vs. 45.5%, = 0.004). Primary liver cancers were more likely to be solitary (72.7% vs. 17.5%, < 0.001), have smooth margins (63.6% vs. 21.4%, = 0.002), exhibit arterial phase hyperenhancement (81.8% vs. 23.8%, < 0.001), and portal venous washout (72.7% vs. 19.0%, < 0.001). Vascular invasion was more common in primary liver cancer (45.5% vs. 11.1%, = 0.01). AFP levels > 400 ng/mL were significantly associated with primary liver cancer (63.6% vs. 4.8%, < 0.001). ROC curve analysis showed that a combination of imaging features had an area under the curve (AUC) of 0.91 for differentiating the two entities. Imaging features such as lesion number, margin characteristics, enhancement patterns, T1/T2 signal characteristics, and portal venous washout, along with pathological features like vascular invasion and AFP levels, can effectively differentiate liver metastases from primary liver cancer. The diagnostic accuracy of imaging is high when multiple features are combined.

摘要

本研究旨在识别和分析在组织病理学确诊的患者中区分肝转移瘤与原发性肝癌的影像学和病理学特征,并评估成像模态的诊断准确性。这项回顾性研究纳入了2016年至2024年间接受肝脏活检或切除术的137例患者,其中包括126例肝转移瘤患者和11例原发性肝癌(肝细胞癌)患者。评估了对比增强MRI上的影像学特征,包括病灶数量、大小、边缘、强化模式、包膜存在情况、T1/T2信号特征、扩散加权成像(DWI)信号以及门静脉血栓形成。收集了肝功能检查和甲胎蛋白(AFP)水平等实验室数据。记录的病理学特征包括肿瘤分化、血管侵犯、坏死和纤维化。采用卡方检验、t检验和逻辑回归进行统计分析,显著性水平设定为<0.05。使用受试者操作特征(ROC)曲线分析评估影像学特征的诊断准确性。肝转移瘤更易表现为多发病灶(82.5%对27.3%,<0.001),边缘不规则(78.6%对36.4%,=0.002),呈环形强化(74.6%对18.2%,<0.001),且在T1加权图像上呈低信号(85.7%对45.5%,=0.004)。原发性肝癌更易为单发(72.7%对17.5%,<0.001),边缘光滑(63.6%对21.4%,=0.002),动脉期呈高强化(81.8%对23.8%,<0.001),且门静脉期有廓清(72.7%对19.0%,<0.001)。血管侵犯在原发性肝癌中更常见(45.5%对11.1%,=0.01)。AFP水平>400 ng/mL与原发性肝癌显著相关(63.6%对4.8%,<0.001)。ROC曲线分析表明,联合影像学特征区分这两种实体的曲线下面积(AUC)为0.91。病灶数量、边缘特征、强化模式、T1/T2信号特征和门静脉期廓清等影像学特征,以及血管侵犯和AFP水平等病理学特征,可有效区分肝转移瘤与原发性肝癌。联合多种特征时,成像的诊断准确性较高。

相似文献

2
[MRI findings of liver metastases from clear cell renal carcinoma and analysis of the impact of adjuvant therapy].
Zhonghua Yi Xue Za Zhi. 2025 May 13;105(18):1431-1435. doi: 10.3760/cma.j.cn112137-20240923-02170.
4
Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
World J Gastroenterol. 2020 Jul 21;26(27):3938-3951. doi: 10.3748/wjg.v26.i27.3938.
7
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
JHEP Rep. 2020 Mar 9;2(3):100097. doi: 10.1016/j.jhepr.2020.100097. eCollection 2020 Jun.
9
Identifying Primary Sites of Spinal Metastases: Expert-Derived Features vs. ResNet50 Model Using Nonenhanced MRI.
J Magn Reson Imaging. 2025 Jul;62(1):176-186. doi: 10.1002/jmri.29720. Epub 2025 Jan 27.
10
[The nomogram model and its value study of Gd-EOB-DTPA enhanced MRI for preoperative diagnosis of proliferative hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi. 2024 Nov 20;32:1-10. doi: 10.3760/cma.j.cn501113-20240509-00246.

本文引用的文献

2
Benign and malignant focal liver lesions displaying rim arterial phase hyperenhancement on CT and MRI.
Insights Imaging. 2024 Jul 18;15(1):178. doi: 10.1186/s13244-024-01756-y.
4
5
Liver metastases: The role of magnetic resonance imaging.
World J Gastroenterol. 2023 Sep 28;29(36):5180-5197. doi: 10.3748/wjg.v29.i36.5180.
9
Liver Metastases: Correlation between Imaging Features and Pathomolecular Environments.
Radiographics. 2022 Nov-Dec;42(7):1994-2013. doi: 10.1148/rg.220056. Epub 2022 Sep 23.
10
Current Imaging Diagnosis of Hepatocellular Carcinoma.
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验